"We screened the Investors Business Daily (IBD) and Zacks databases to find companies whose earnings are accelerating and whose earnings estimates are being increased by analysts," says J. Royden Ward.

The editor of the Cabot Benjamin Graham Value Letter continues, "All of the stocks in our list have IBD Composite Ratings of 95 (99 is best) and Zacks Ratings of 1 or 2 (1 is best). These recommendations offer excellent appreciation potential with moderate risk.

"The Canadian economy performed much better than the U.S. economy during the past two and a half years," says J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "We believe many outstanding buying opportunities still exist and investors should continue to buy undervalued Canadian stocks."

Here, he looks at a trio of Canadian-based resource plays: Barrick Resources (ABX), Pan American Silver (PAAS), and Teck Resources 'B' (TCK).

This post is one in a series in which more than 60 newsletter advisors share their Top Stock Picks for 2011. This special report is courtesy of TheStockAdvisors.com.

"Arrow Electronics (ARW) s a classic value stock with low price-to-earnings and price-to-book value ratios. Founded in 1935 and based in Melville, New York," notes J. Royden Ward.

The editor of the Cabot Benjamin Graham Value Letter explains, "Arrow is the second largest distributor of electronic components and computer products, serving 900 suppliers throughout North America, Europe and Asia.

"Quality companies with low price-to-book value ratios (P/BV) have outperformed companies with higher valuations for the past three-, five- and 10-year periods," says J. Royden Ward.

The editor of the Cabot Benjamin Graham Value Letter explains, "Our search for undervalued companies to with price to book value ratios found three stocks in tech-related sectors: Kyocera (KYO), PC Connection (PCCC), and Thermo Fisher Scientific (TMO).

"To find the best stocks with low price-to-book value ratios, we required Value Line Financial Strength ratings of A or better, dividend payments increasing over time, low P/E ratios and good earnings prospects for the next 12-month and five-year periods.

"Research In Motion (RIMM) is clearly undervalued at 9.7 times forward EPS; investor's concerns regarding the intense competition in the smart phone market have caused the stock price to decline 26% during the past seven months," says value investor J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "We believe exciting new product introductions will boost sales and earnings growth more than expected during the next couple of years.

"Among our latest buy recommendations -- based on the value investing strategy of Ben Graham -- we like Gilead Sciences (GILD) and Teva Pharmaceutical (TEVA)," says J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "Gilead is a biopharmaceutical company that discovers, develops and markets therapeutic treatments to combat viral, bacterial and fungal infections. Its shares undervalued at 9.7 times forward 12-month EPS.

"Teva, based in Israel, develops, makes and sells generic and proprietary-branded (store brand) drugs. Its shares are clearly undervalued at 10.6 times forward EPS. We consider both stocks to be very low risk.

"Benjamin Graham has been recognized for decades as the father of value investing; Warren Buffett is known as the Oracle of Omaha for his superior investing skills," asserts J. Royden Ward, adding, "For this report, we combine Warren Buffett's and Ben Graham's criteria for choosing stocks.

The advisor reviews Abbott Laboratories (ABT), Coach (COH), Intel (INTC), Mastercard (MA), Microsoft (MSFT) and Tupperware Brands (TUP).

"Investing in conservative stocks to build or rebuild the core of your portfolio makes sense right now; investors should buy companies that have a long history of steady earnings and dividend growth, through good times and tough times," says J. Royden Ward.

The editor of the specialty newsletter, Cabot Benjamin Graham Value Letter, explains, "The obvious benefit of adhering to a disciplined system of value investing like ours is that you build long-term profits and, ideally, financial independence.

"The stock market is now below the midpoint of fair valuation, a fact that leads us to believe there is further upside for the market ahead," says J. Royden Ward, who specializes in uncovering value-oriented investments.

The editor of Cabot Benjamin Graham Value Letter explains, "Our goal is to identify value and one such value, in our view, is Wal-Mart Stores (WMT), the world's largest retailer, employing more than two million workers in more than 7,500 stores.

"Is SkyWest (SKYW) undervalued? Indeed, we believe the shares are undervalued at only 0.55 times current book value," says J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "The company's P/E of 8.4 and dividend yield of 1.1% is attractive. SkyWest alo has over $13 per share in cash ready to expand its operations. In our view, SkyWest is a classic Benjamin Graham stock.

"We believe many outstanding buying opportunities are available among these undervalued foreign stocks; we screened the Zacks, Investors Business Daily, S&P and Value Line databases to find foreign companies with rapidly growing earnings," says J. Royden Ward.

The editor of Cabot Benjamin Graham Value Letter explains, "We believe these six companies offer excellent appreciation potential at reasonable prices: Lululemon Athletica (LULU), Mindray Medical (MR), Potash (POT), Seagate Technology (STX), Silver Wheaton (SLW) and Telefonica SA (TEF)."

This post is part of a special report, Top Picks for 2010, the 27th annual survey in which TheStockAdvisors.com asks the nation's leading advisors for their single favorite stock for the new year. See all 80 stocks listed here.

J. Royden Ward is the editor of The Cabot Benjamin Graham Value Letter, a newsletter that -- as its name suggests -- focuses on stocks that meet the criteria of legendary value investor Ben Graham.

For his top pick for 2010, he the advisor looks to Amedisys (AMED), a provider of home health care and hospice services.

The Cabot Benjamin Graham Value Letter focuses on stocks that meet the strict value criteria of the legendary investor. Here, J. Royden Ward looks to Teva Pharmaceutical (NASDAQ: TEVA), noting, "Teva is based in Israel and develops, makes and sells generic and proprietary-branded (store brand) drugs."

The advisor explains, "The company is one of the largest generic drug-producing companies in the world and, in addition, sells active ingredients to other pharmaceutical companies.

"Teva's aggressive acquisition and product development programs are driving strong sales growth. The company recently purchased U.S.-based Barr Pharmaceuticals for $7.5 billion. Barr will increase Teva's generic drug sales significantly in the U.S. and parts of Europe.

In The Cabot Benjamin Graham Value Letter, editor J. Royden Ward searches for stocks that meet the investing criteria of the legendary Ben Graham, known as the father of value investing and mentor of Warren Buffett.

Here, the advisor takes a look at Overseas Shipholding Group (NYSE: OSG), a crude oil and energy shipping operation.

"Overseas Shipholding is a leading crude oil and energy shipping company with 120 vessels either owned or leased. In addition, the company derives 25% of revenues from grain, coal, and iron ore.

In The Cabot Benjamin Graham Value Letter -- which assesses stocks based on Graham's value investing critera, editor J. Royden Ward takes a look at Wal-Mart Stores (NYSE: WMT).

"In this month's Classic Benjamin Graham Value Model, our calculation suggests that the Dow is overvalued at 12,370 and undervalued at 8,305; as such, today the market is extremely undervalued.

"This low-risk environment means it's probably a great time to add risk by dabbling in our recommended stocks such as Wal-Mart Stores.

"How cheap is it? The recent decline in WMT shares has created an outstanding buying opportunity for investors. WMT shares now sell at only 12.3 times forward EPS with a dividend yield of 2.0%.